Charles A. Deignan, Chief Financial Officer at Clearside Biomedical, Inc. (CLSD), sold 8,833 shares at $2.09 ($18K) on 2022-01-19, disclosed to the SEC on 2022-01-20.
Scheduled sale ($18k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CLSD | SELL | 2021-09-23 | $18K | — | Filing → |
| CLSD | SELL | 2021-06-23 | $13K | — | Filing → |
| CLSD | SELL | 2020-06-03 | $28K | — | Filing → |